Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Impact of Surfactant Protein-D Gene Polymorphism on COVID-19 Clinical Outcomes.

Immunity, inflammation and disease - 1 May 2026

Kolsari Nadia Nasirzadeh, Azaran Azarakhsh, Pirmoradi Roya, Moradi Maryam, Nashibi Roohangiz, Jalilian Shahram

Abstract excerpt

BACKGROUND: COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents a broad spectrum of clinical manifestations, ranging from asymptomatic cases to severe, life-threatening respiratory complications. Pulmonary surfactant-associated protein D (SP-D) is a critical component of pulmonary immune defense. The objective of this study was to investigate the association between a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Hospitalization

Share to Polymorphism, Single Nucleotide

Share to Pulmonary Surfactant-Associated Protein D

Share to SARS-CoV-2

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 42139264
DOI: 10.1002/iid3.70410
PMCID: PMC13178794

Genes

SFTPD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Impact of Surfactant Protein-D Gene Polymorphism on COVID-19 Clinical Outcomes.PMID 42139264Read ↗

Surfactant protein levels and genetic variants as biomarkers for COVID-19 severity in children.Semantic proximity Read ↗

Linking surfactant proteins and genetic variants to COVID-19 severitySemantic proximity Read ↗

Altered Surfactant Protein Gene Expression in Peripheral Blood Is Associated with COVID-19 Disease SeveritySemantic proximity Read ↗

SFTPB (rs11130866) and NR3C1 (rs41423247) gene variants as potential clinical biomarkers for personalized treatment strategy selection in patients with severe COVID-19 pneumonia.Semantic proximity Read ↗

Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.Semantic proximity Read ↗

Association between TMPRSS2 rs2070788 polymorphism and COVID-19 severity: a case-control study in multiple cities of IranSemantic proximity Read ↗

Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced.Semantic proximity Read ↗

The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and OutcomesSemantic proximity Read ↗

Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.Semantic proximity Read ↗

Surfactant proteins as genetic determinants of multifactorial pulmonary diseases.Semantic proximity Read ↗

Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.Semantic proximity Read ↗

Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.